Literature DB >> 31802304

Response to: Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions.

Alexandru Barboi1,2,3, Christopher H Gibbons4,5, Eduardo E Bennaroch6,5, Italo Biaggioni7,5, Mark W Chapleau8,9,10,5, Gisela Chelimsky11,5, Thomas Chelimsky12,5, William P Cheshire13,5, Victoria E Claydon14,5, Roy Freeman4,5, David S Goldstein15,5, Michael J Joyner4,5, Horacio Kaufmann16,5, Phillip A Low6,5, Lucy Norcliffe-Kaufmann5,17,18, David Robertson7,5, Cyndya A Shibao7,5, Wolfgang Singer6,5, Howard Snapper5,19, Steven Vernino5,20, Satish R Raj7,5,21.   

Abstract

Entities:  

Year:  2019        PMID： 31802304     DOI： 10.1007/s10286-019-00650-8

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  6 in total

1.  The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.

Authors:  Jozica Skufca; Jukka Ollgren; Miia Artama; Esa Ruokokoski; Hanna Nohynek; Arto A Palmu
Journal:  Vaccine       Date:  2018-08-13       Impact factor: 3.641

Review 2.  Human Papillomavirus Vaccine and Postural Orthostatic Tachycardia Syndrome: A Review of Current Literature.

Authors:  Breann N Butts; Philip R Fischer; Kenneth J Mack
Journal:  J Child Neurol       Date:  2017-07-10       Impact factor: 1.987

Review 3.  Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society.

Authors:  Alexandru Barboi; Christopher H Gibbons; Felicia Axelrod; Eduardo E Benarroch; Italo Biaggioni; Mark W Chapleau; Gisela Chelimsky; Thomas Chelimsky; William P Cheshire; Victoria E Claydon; Roy Freeman; David S Goldstein; Michael J Joyner; Horacio Kaufmann; Phillip A Low; Lucy Norcliffe-Kaufmann; David Robertson; Cyndya A Shibao; Wolfgang Singer; Howard Snapper; Steven Vernino; Satish R Raj
Journal:  Clin Auton Res       Date:  2019-09-02       Impact factor: 4.435

4.  Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions.

Authors:  Svetlana Blitshteyn
Journal:  Clin Auton Res       Date:  2019-12-12       Impact factor: 4.435

5.  Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®.

Authors:  Rebecca E Chandler; Kristina Juhlin; Jonas Fransson; Ola Caster; I Ralph Edwards; G Niklas Norén
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

6.  Incidence rates of Guillain Barré (GBS), chronic fatigue/systemic exertion intolerance disease (CFS/SEID) and postural orthostatic tachycardia syndrome (POTS) prior to introduction of human papilloma virus (HPV) vaccination among adolescent girls in Finland, 2002-2012.

Authors:  J Skufca; J Ollgren; E Ruokokoski; O Lyytikäinen; H Nohynek
Journal:  Papillomavirus Res       Date:  2017-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.